• About
  • Archive
  • China Business Review Historical Archive
  • Contact
  • Home 1
  • Submit a Story
  • Submit a Story
  • USCBC Podcasts
China Business Review
  • Operations
    Multinational Supply Chains in a Post-Pandemic China

    Multinational Supply Chains in a Post-Pandemic China

    Managing Risk in the “New Era”

    Managing Risk in the “New Era”

    Design Patents vs. Trade Dress: Protecting IP in China

    Design Patents vs. Trade Dress: Protecting IP in China

    As China Emerges from COVID-19, US Companies Invest to Compete

    As China Emerges from COVID-19, US Companies Invest to Compete

    Inside the Mad Rush for Masks – Anatomy of a 10 Million Mask Order

    Inside the Mad Rush for Masks – Anatomy of a 10 Million Mask Order

    Addressing Risk in the Era of US-China “Great Power” Competition

    Addressing Risk in the Era of US-China “Great Power” Competition

  • Politics
    Hong Kong’s National Security Law, Five Months In

    Hong Kong’s National Security Law, Five Months In

    China Implements its Long-Awaited Unreliable Entities List Mechanism

    China Implements its Long-Awaited Unreliable Entities List Mechanism

    Competing WTO Reform Agendas and the Contest for the Next Director-General

    Competing WTO Reform Agendas and the Contest for the Next Director-General

    China Eyes Further Northeast Asian Economic Integration in RCEP

    China Eyes Further Northeast Asian Economic Integration in RCEP

    COVID-19 Could Doom or Deliver US-China Commercial Relations

    COVID-19 Could Doom or Deliver US-China Commercial Relations

    A Game of Chicken

    A Game of Chicken

  • Tech
    China and CPTPP: Does China’s Emerging Data Regime Live Up to CPTPP Principles?

    China and CPTPP: Does China’s Emerging Data Regime Live Up to CPTPP Principles?

    Can China’s Beleaguered Gaming Industry Overcome the New Wave of Restrictions?

    Can China’s Beleaguered Gaming Industry Overcome the New Wave of Restrictions?

    Semiconductor Self-Sufficiency: MIIT’s Ambitions for 2021 and Beyond

    Semiconductor Self-Sufficiency: MIIT’s Ambitions for 2021 and Beyond

    The Growing Intersection of Digital Health and Data Processing in China

    The Growing Intersection of Digital Health and Data Processing in China

    Export Controls on Emerging and Foundational Technologies: A Null Set?

    Export Controls on Emerging and Foundational Technologies: A Null Set?

    How Companies Are Reacting to China’s New Data Security Scheme

    How Companies Are Reacting to China’s New Data Security Scheme

    Trending Tags

    • Intellectual Property
    • innovation
    • cybersecurity
    • ecommerce
    • tech
  • Society
    Can China’s Beleaguered Gaming Industry Overcome the New Wave of Restrictions?

    Can China’s Beleaguered Gaming Industry Overcome the New Wave of Restrictions?

    China Cracks Down on Education Industry in Effort to Increase Birthrate

    China Cracks Down on Education Industry in Effort to Increase Birthrate

    The Extraordinary Rise of China’s Pet Industry

    The Extraordinary Rise of China’s Pet Industry

    COVID-19 Could Doom or Deliver US-China Commercial Relations

    COVID-19 Could Doom or Deliver US-China Commercial Relations

    The Year in Social Credit: Where is Corporate Social Credit Going in 2020 and Beyond?

    The Year in Social Credit: Where is Corporate Social Credit Going in 2020 and Beyond?

    Open Government Developments in China: Implications for US Businesses

  • Media

    Gallery: Craig Allen’s Trip to China

    USCBC 45th Annual Membership Meeting

    USCBC 45th Anniversary DC Open House

    USCBC President’s China Visit

    USCBC Hosts Business Roundtable with Zhejiang Party Secretary Che Jun

    USCBC hosts Comprehensive Economic Dialogue (CED) Luncheon

  • Podcasts
  • Archive
No Result
View All Result
  • Operations
    Multinational Supply Chains in a Post-Pandemic China

    Multinational Supply Chains in a Post-Pandemic China

    Managing Risk in the “New Era”

    Managing Risk in the “New Era”

    Design Patents vs. Trade Dress: Protecting IP in China

    Design Patents vs. Trade Dress: Protecting IP in China

    As China Emerges from COVID-19, US Companies Invest to Compete

    As China Emerges from COVID-19, US Companies Invest to Compete

    Inside the Mad Rush for Masks – Anatomy of a 10 Million Mask Order

    Inside the Mad Rush for Masks – Anatomy of a 10 Million Mask Order

    Addressing Risk in the Era of US-China “Great Power” Competition

    Addressing Risk in the Era of US-China “Great Power” Competition

  • Politics
    Hong Kong’s National Security Law, Five Months In

    Hong Kong’s National Security Law, Five Months In

    China Implements its Long-Awaited Unreliable Entities List Mechanism

    China Implements its Long-Awaited Unreliable Entities List Mechanism

    Competing WTO Reform Agendas and the Contest for the Next Director-General

    Competing WTO Reform Agendas and the Contest for the Next Director-General

    China Eyes Further Northeast Asian Economic Integration in RCEP

    China Eyes Further Northeast Asian Economic Integration in RCEP

    COVID-19 Could Doom or Deliver US-China Commercial Relations

    COVID-19 Could Doom or Deliver US-China Commercial Relations

    A Game of Chicken

    A Game of Chicken

  • Tech
    China and CPTPP: Does China’s Emerging Data Regime Live Up to CPTPP Principles?

    China and CPTPP: Does China’s Emerging Data Regime Live Up to CPTPP Principles?

    Can China’s Beleaguered Gaming Industry Overcome the New Wave of Restrictions?

    Can China’s Beleaguered Gaming Industry Overcome the New Wave of Restrictions?

    Semiconductor Self-Sufficiency: MIIT’s Ambitions for 2021 and Beyond

    Semiconductor Self-Sufficiency: MIIT’s Ambitions for 2021 and Beyond

    The Growing Intersection of Digital Health and Data Processing in China

    The Growing Intersection of Digital Health and Data Processing in China

    Export Controls on Emerging and Foundational Technologies: A Null Set?

    Export Controls on Emerging and Foundational Technologies: A Null Set?

    How Companies Are Reacting to China’s New Data Security Scheme

    How Companies Are Reacting to China’s New Data Security Scheme

    Trending Tags

    • Intellectual Property
    • innovation
    • cybersecurity
    • ecommerce
    • tech
  • Society
    Can China’s Beleaguered Gaming Industry Overcome the New Wave of Restrictions?

    Can China’s Beleaguered Gaming Industry Overcome the New Wave of Restrictions?

    China Cracks Down on Education Industry in Effort to Increase Birthrate

    China Cracks Down on Education Industry in Effort to Increase Birthrate

    The Extraordinary Rise of China’s Pet Industry

    The Extraordinary Rise of China’s Pet Industry

    COVID-19 Could Doom or Deliver US-China Commercial Relations

    COVID-19 Could Doom or Deliver US-China Commercial Relations

    The Year in Social Credit: Where is Corporate Social Credit Going in 2020 and Beyond?

    The Year in Social Credit: Where is Corporate Social Credit Going in 2020 and Beyond?

    Open Government Developments in China: Implications for US Businesses

  • Media

    Gallery: Craig Allen’s Trip to China

    USCBC 45th Annual Membership Meeting

    USCBC 45th Anniversary DC Open House

    USCBC President’s China Visit

    USCBC Hosts Business Roundtable with Zhejiang Party Secretary Che Jun

    USCBC hosts Comprehensive Economic Dialogue (CED) Luncheon

  • Podcasts
  • Archive
No Result
View All Result
China Business Review
No Result
View All Result
Home Innovation

Healthcare Series Part 2: New Bidding and Tendering Law Promising for Healthcare Companies, If Implemented

USCBC by USCBC
November 22, 2017
Share on FacebookShare on TwitterLinkedin

By David Solomon

Chinese regulations on tendering and bidding practices published by the Ministry of Finance (MOF) in July are a promising sign for US pharmaceutical and medical device manufacturers that government procurement behavior will be better regulated to guarantee consideration of quality alongside price. However, true improvement for the industry will require regulators to faithfully implement the law and refrain from unofficial practices such as local favoritism, which sometimes plague procurement processes.

The existing law, which has governed drug and device procurement since 2003, called upon an assessment committee to equally evaluate product quality and price in determining selections. However, concerns over shrinking public healthcare insurance funds have placed greater pressure on the committee to disproportionately consider price over quality.

Although certain products were awarded contracts for meeting the highest standard performance threshold, the system often favored more inexpensive products that only met minimum quality standards. At times, these products were priced so inexpensively they did not reflect actual production costs. This influenced some companies to seek market access by being the lowest bidder in their product category, regardless of quality and performance. As a consequence, the assessment committee often favored low-priced generics over foreign-produced originator drugs and devices with superior product quality.

To improve this system, the new law requires the assessment committee to ensure low-price bids do not neglect quality. The law stipulates that when a bid is considerably lower than the average price offered by competitors, the committee will determine if the low price implies poor product quality or performance. The bidder is required to provide a written statement and relevant materials that justify the low price of the product. Should the bidder fail to provide an adequate rationale for the low price, the committee will dismiss the bid.

This adjustment could incentivize higher quality and performance standards for all drug and device manufacturers seeking Chinese market access. A stronger emphasis on quality could favor foreign companies’ products, which generally have quality and performance advantages over their domestic competitors.

While this is major step forward in reforming the drug and device evaluation system, the law must be implemented in good faith to have a positive effect.

Other unofficial factors also influence provincial bid selections, such as consideration toward candidates that have set up factories—and pay taxes—within a particular province. Candidates in national high-tech industrial parks have also received further consideration in the past. Because provincial assessment committees frequently include such criteria, which disregard quality and performance, local bidders can have advantages over outside competition in these situations. For the new law to achieve its goals, it will need to be implemented as drafted to offer a fairer playing field for foreign and domestic companies during assessment periods.

David Solomon is a Business Advisory Manager for the US-China Business Council, a private, nonpartisan, nonprofit organization of more than 200 American companies that do business with China. 

USCBC

USCBC

Next Post

IT Solutions: Improving Efficiency, Accuracy and Transparency in Payroll Processing in China

Recommended.

China and CPTPP: Does China’s Emerging Data Regime Live Up to CPTPP Principles?

August 5, 2022

Reflections on the Phase One Agreement

January 20, 2022

Can China’s Beleaguered Gaming Industry Overcome the New Wave of Restrictions?

November 29, 2021

From Reshoring to Rightshoring: Dr. Sara Hsu on the Future of US-China Supply Chains

August 4, 2021

Latest Podcasts.

What recent chip export controls mean for business

January 25, 2023

Taking stock as we enter USCBC’s 50th year

January 13, 2023

What unexpected midterm results mean for China policy

November 16, 2022

Two tales of travel to China

November 7, 2022
China Business Review

China Business Review is the official magazine of the US-China Business Council, a nonprofit and nonpartisan trade association that represents more than 200 American companies doing business in China.

  • How to contribute to China Business Review

Categories

  • Bilateral Relations
  • Business Etiquette
  • CBR Spotlight
  • China Deals
  • Corruption
  • Cybersecurity
  • Ecommerce
  • Environment
  • Finance
  • Galleries
  • Getting Started
  • HR & Staffing
  • Infographics
  • Innovation
  • Intellectual Property
  • Management
  • Media
  • Operations
  • Opinion
  • Policy & Regulations
  • Politics
  • PR & Marketing
  • Rural Issues
  • Safety
  • Social Policy
  • Society
  • Standards + Licensing
  • Sustainability
  • Tax
  • Tech
  • Top Story
  • Trade
  • Uncategorized
  • US-China Business Council
  • Videos

Tags

Agreements Agriculture Alibaba Best Practices Business Environment China China's Investments Abroad China Market Intelligence Chinese Consumers Chinese Investment Commentary Consumer Trends E-Commerce Economic Trends Energy Environment Events Food Foreign Investment Going Global Healthcare Reform Human Resources Infrastructure Internet Interview Investment Investments into China IPO Joint Venture Labor Legal Analysis M&A Manufacturing Media National People's Congress Q&A Strategic and Economic Dialogue Supply Chains Technology Trade Transparency US-China Relations USCBC US Exports to China Xi Jinping

Join our Mailing List

Sign up for the US-China Business Council's newsletters to stay ahead of the game with roundups, analysis, and commentary.

Sign Up

Follow Us

  • About
  • USCBC
  • Submit a Story
  • Archive

© 2022 China Business Review

No Result
View All Result
  • Operations
  • Politics
  • Tech
  • Society
  • Media
  • Podcasts
  • Archive

© 2022 China Business Review